Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04649060 |
|---|---|
| Brief Title: | Study of Melflufen (Melphalan Flufenamide) in Combination With Daratumumab in Relapsed-Refractory Multiple Myeloma (LIGHTHOUSE) |
| First Submitted : | November 24, 2020 |
| First Submitted that Met QC Criteria : | November 24, 2020 |
| First Posted : | December 2, 2020 |
| Results First Submitted : | February 7, 2023 |
| Results First Posted with QC Comments : | March 8, 2023 |
| Results First Submitted that Met QC Criteria : | May 12, 2023 |
| Results First Posted : | June 8, 2023 |
| Last Update Submitted that Met QC Criteria : | May 12, 2023 |
| Last Update Posted : | June 8, 2023 |